Pacer Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.16M Buy
27,893
+5,757
+26% +$1.59M 0.02% 624
2026
Q1
$6.54M Sell
22,136
-10,712
-33% -$3.18M 0.02% 552
2025
Q4
$8.97M Buy
32,848
+3,317
+11% +$901K 0.02% 519
2025
Q3
$7.98M Sell
29,531
-5,812
-16% -$1.58M 0.02% 548
2025
Q2
$9.74M Buy
35,343
+11,306
+47% +$3.07M 0.02% 501
2025
Q1
$6.38M Sell
24,037
-13,020
-35% -$3.21M 0.01% 576
2024
Q4
$8.61M Sell
37,057
-9,451
-20% -$2.17M 0.02% 491
2024
Q3
$10.3M Buy
46,508
+9,905
+27% +$2.05M 0.02% 457
2024
Q2
$7.2M Sell
36,603
-858
-2% -$177K 0.02% 501
2024
Q1
$8.06M Sell
37,461
-2,545
-6% -$535K 0.02% 477
2023
Q4
$8.43M Buy
40,006
+17,302
+76% +$3.69M 0.02% 438
2023
Q3
$4.55M Sell
22,704
-4,286
-16% -$852K 0.02% 481
2023
Q2
$5M Sell
26,990
-718
-3% -$133K 0.02% 524
2023
Q1
$5.31M Sell
27,708
-31,647
-53% -$5.72M 0.02% 532
2022
Q4
$9.98M Buy
59,355
+58,622
+7,998% +$10.2M 0.05% 340
2022
Q3
$130K Buy
733
+161
+28% +$31.8K ﹤0.01% 1799
2022
Q2
$117K Sell
572
-17,898
-97% -$3.79M ﹤0.01% 1956
2022
Q1
$4.39M Sell
18,470
-503
-3% -$118K 0.04% 452
2021
Q4
$4.33M Sell
18,973
-964
-5% -$212K 0.04% 512
2021
Q3
$3.85M Sell
19,937
-152
-0.8% -$30.8K 0.05% 500
2021
Q2
$4.27M Sell
20,089
-933
-4% -$197K 0.06% 398
2021
Q1
$4.29M Sell
21,022
-1,275
-6% -$251K 0.07% 282
2020
Q4
$4.06M Sell
22,297
-2,451
-10% -$417K 0.08% 231
2020
Q3
$4.14M Sell
24,748
-5,434
-18% -$915K 0.09% 178
2020
Q2
$4.91M Buy
+30,182
New +$5.41M 0.1% 154
2020
Q1
Sell
-41,386
Closed -$8.31M 751
2019
Q4
$8.31M Buy
41,386
+2,949
+8% +$605K 0.38% 42
2019
Q3
$8.12M Buy
38,437
+4,606
+14% +$962K 0.18% 94
2019
Q2
$6.57M Buy
33,831
+4,048
+14% +$746K 0.16% 105
2019
Q1
$4.9M Buy
+29,783
New +$5.27M 0.14% 124
2018
Q4
Sell
-17,839
Closed -$3.04M 639
2018
Q3
$3.04M Buy
17,839
+2,228
+14% +$375K 0.11% 171
2018
Q2
$2.56M Buy
15,611
+1,289
+9% +$211K 0.12% 183
2018
Q1
$2.32M Buy
14,322
+2,760
+24% +$439K 0.13% 163
2017
Q4
$1.69M Buy
11,562
+4,121
+55% +$587K 0.12% 203
2017
Q3
$1.01M Buy
7,441
+932
+14% +$118K 0.09% 287
2017
Q2
$815K Buy
6,509
+500
+8% +$59.8K 0.08% 338
2017
Q1
$714K Buy
6,009
+192
+3% +$23.1K 0.09% 314
2016
Q4
$671K Sell
5,817
-34
-0.6% -$3.78K 0.1% 267
2016
Q3
$612K Sell
5,851
-34
-0.6% -$3.55K 0.09% 270
2016
Q2
$573K Buy
5,885
+216
+4% +$20.4K 0.09% 261
2016
Q1
$545K Buy
5,669
+392
+7% +$35.7K 0.12% 176
2015
Q4
$478K Buy
+5,277
New +$497K 0.11% 180

Other funds holding CME

Pacer Advisors's CME Position: Q2 2026 in Review

Pacer Advisors increased its CME Group (CME) stake by 26% in Q2 2026, buying an estimated $1.59M and bringing the position to 27,893 shares worth $6.16M. The position accounts for 0.02% of the portfolio, ranked #624.

Pacer Advisors first reported a position in CME in Q4 2015 and has held it in 41 quarters since. The position peaked at $10.3M in Q3 2024. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Pacer Advisors held 27,893 shares of CME Group worth $6.16M as of Q2 2026.
  • Pacer Advisors bought 5,757 CME Group shares in Q2 2026, an estimated $1.59M.
  • CME Group made up 0.02% of Pacer Advisors's portfolio in Q2 2026, its #624 holding.
  • Pacer Advisors first reported a position in CME Group in Q4 2015 and has held it in 41 quarters since.
  • Pacer Advisors's CME Group position peaked at $10.3M in Q3 2024.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.